189
Results-
Press ReleaseRARE DISEASE DAY – February 28th, 2023Created on : - Last modified on :Pierre Fabre pursues its commitment against rare diseases in the pediatric, oncology and dermatology fields. The diseases are rare, but they impact a lot of people : nearly 300 million people are affected worldwide1.
-
Press ReleaseMarie-Andrée GAMACHE joins Pierre Fabre Laboratories as CEO of the Medical CareCreated on : - Last modified on :Castres (France), March 31, 2025 – Pierre Fabre Laboratories has announced the appointment of Marie-Andrée Gamache as Chief Executive Officer (CEO) of its Medical Care. In this capacity, Marie-Andrée Gamache joins the Group’s Executive Committee and reports to Eric Ducournau, Group CEO.
-
News2023 Annual Report: Taking care of you helps us advanceCreated on : - Last modified on :In 2023, we have chosen to tell you a shared story through our annual report: that of a Group convinced that “Taking care of you helps us advance,” and which places this conviction at the heart of its action.
-
NewsMelanoma Awareness Month – We Have Your BackCreated on : - Last modified on :Malignant melanoma is a type of skin cancer that starts and develops in cells known as melanocytes – these cells are found in the upper layer of the skin and produce a pigment called melanin, giving skin its colouri. Melanoma, although less common than other skin cancers, is more dangerous because it grows and spreads quickly to other parts of the body if undetected and not treated early.i ii,
-
NewsAnne-Sophie Paradis: A Medical Science Liaison (MSL) Bridging Science and Patient Care in FranceCreated on : - Last modified on :The script of video.
-
NewsPIERRE FABRE, 60 YEARS OF CARING FOR EVERYONECreated on : - Last modified on :In 1962, as a young pharmacist, Pierre Fabre embarked on innovation by creating his first drug. 60 years later, under the governance of our Public Utility Foundation Pierre Fabre, we continue to nurture our unique positioning, at the crossroads of the medical and the natural, to provide access to the highest quality care, based on our expertise in oncology, dermatology and dermocosmetics. This year we celebrate 60 years of partnership and trust, serving our patients and consumers.
-
NewsCHANGING THE WAY WE LOOK AT VISIBLE DERMATOSESCreated on : - Last modified on :The first international epidemiological study on the prevalence and psychosocial impact of visible chronic dermatoses conducted on over 13,000 people Dermatoses such as eczema, hand eczema, acne, psoriasis, ichthyosis, vitiligo, and rosacea do not impair vital functions, but can significantly affect quality of life.
-
NewsRecent updates in BRAFV600E-mutant metastatic colorectal cancer treatmentCreated on : - Last modified on :In 2020, almost two million people were diagnosed with colorectal cancer (CRC)1. At present, survival rates for the metastatic CRC (mCRC) population are poor, with less than 20% of people living for more than five years after diagnosis across Europe. Of these patients, 8-12% are diagnosed with a BRAF mutation, 95% of which are BRAFV600E, an aggressive form associated with a poor prognosis.2
-
NewsThe Pierre Fabre group, Platinum Sponsor at the 25th World Congress of Dermatology in SingaporeCreated on : - Last modified on :From July 3rd to 8th, 2023, The Pierre Fabre group, 2nd largest dermo-cosmetics laboratory in the world and 2nd largest private pharmaceutical group in France, will be actively participating in the 25th World Congress of Dermatology in Singapore. As a platinum sponsor of the event, the Group demonstrates its commitment to advancing research and innovation in the specialized fields of dermatology and oncology.
-
NewsTHE GREEN IMPACT INDEX CONSORTIUM IS PLEASED TO ANNOUNCE THE PUBLICATION OF AFNOR SPEC 2215 BY AFNOR:Created on : - Last modified on :The first guide to displaying the environmental and societal impact of cosmetics, food supplements, family health and wellness products, available to all companies, from SMEs to major international groups.
We take care of life by designing and developing innovative solutions inspired by consumers and patients, and contributing to the well-being of everyone from health to beauty.